Recently in NKF/KDOQI Category

NKF/KDOQI: Anemia in Chronic Kidney Disease

By Patrick on January 14, 2010 8:51 PM | No Comments
2.1.2 In the opinion of the Work Group, in dialysis and nondialysis patients with CKD receiving ESA therapy, the selected Hb target should generally be in the range of 11.0 to 12.0 g/dL. (Clinical Practice RECOMMENDATION)

2.1.3 In dialysis and nondialysis patients with CKD receiving ESA therapy, the Hb target should not be greater than 13.0 g/dL. (Clinical Practice GUIDELINE - MODERATELY STRONG EVIDENCE)

KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target

NKF/KDOQI: Erythropoietin & Hemoglobin Target

By Patrick on October 20, 2009 11:49 PM | No Comments

2.1.3 In dialysis and nondialysis patients with CKD receiving ESA therapy, the Hb target should not be greater than 13.0 g/dL. (Clinical Practice GUIDELINE - MODERATELY STRONG EVIDENCE)

 

KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target

« IDSA | Main Index | Archives | USPSTF »

Categories

Monthly Archives

Search

Recent Entries

Recent Comments

  • Patrick: Guidelines are meant to be guidelines. In the IDSA recommendation, read more
  • Alifeya: an example, 80 y/o nursing home resident with severe dementia read more
  • Patrick: The IDSA guidelines for uncomplicated cystitis excluded studies where >2% read more
  • mbazylewicz: Does a fever (unidentified source) with no dysuria, frequency, urgency, read more